|
94 |
Inadequate Classification leads to Warning Letter
|
sureAssist |
2024-12-26 |
873 |
|
93 |
FDA criticises the Use of pharmaceutical Facilities for industrial Products
|
sureAssist |
2024-12-26 |
861 |
|
92 |
GMP Requirements for Ready to Sterilize (RTS) and Ready to Use (RTU) Containers
|
sureAssist |
2024-12-26 |
904 |
|
91 |
Modular vs panellised: A guide to accelerate cleanroom delivery
|
sureAssist |
2024-12-26 |
926 |
|
90 |
Results of ECA Survey about Artificial Intelligence in Equipment Qualification
|
sureAssist |
2024-12-26 |
874 |
|
89 |
Warning Letter to Indian sterile Manufacturer due to Cross-Contamination and Particles
|
sureAssist |
2024-12-26 |
811 |
|
88 |
FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals
|
sureAssist |
2024-12-26 |
893 |
|
87 |
Warning Letter to US Company due to Lack of Product and Process Control
|
sureAssist |
2024-12-26 |
769 |
|
86 |
The IoT edge: Elevating cleanroom monitoring to new heights in the era of Pharma 4.0
|
sureAssist |
2024-12-26 |
800 |
|
85 |
Water system qualification and requalifications: Considerations for microbial identification
|
sureAssist |
2024-12-26 |
1,082 |
